M. Peterson

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

J. Kurtzberg, M. Cairo, J. Garvin, 2014, Leukemia.

Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.

R. Mesa, C. Reeder, R. Tibes, 2012, Leukemia research.

Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial

M. Peterson, Mary E. Peterson, 2013, Supportive Care in Cancer.